000 01653 a2200493 4500
005 20250518100815.0
264 0 _c20210412
008 202104s 0 0 eng d
022 _a1554-8937
024 7 _a10.1021/acschembio.0c00104
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBadr, Christian E
245 0 0 _aObtusaquinone: A Cysteine-Modifying Compound That Targets Keap1 for Degradation.
_h[electronic resource]
260 _bACS chemical biology
_c06 2020
300 _a1445-1454 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacokinetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCinnamates
_xpharmacokinetics
650 0 4 _aCyclohexanones
_xpharmacokinetics
650 0 4 _aCysteine
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKelch-Like ECH-Associated Protein 1
_xmetabolism
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProteolysis
_xdrug effects
700 1 _ada Hora, Cintia Carla
700 1 _aKirov, Aleksandar B
700 1 _aTabet, Elie
700 1 _aAmante, Romain
700 1 _aMaksoud, Semer
700 1 _aNibbs, Antoinette E
700 1 _aFitzsimons, Evelyn
700 1 _aBoukhali, Myriam
700 1 _aChen, John W
700 1 _aChiu, Norman H L
700 1 _aNakano, Ichiro
700 1 _aHaas, Wilhelm
700 1 _aMazitschek, Ralph
700 1 _aTannous, Bakhos A
773 0 _tACS chemical biology
_gvol. 15
_gno. 6
_gp. 1445-1454
856 4 0 _uhttps://doi.org/10.1021/acschembio.0c00104
_zAvailable from publisher's website
999 _c30904928
_d30904928